Oxidative Imbalance in Different Neurodegenerative Diseases with Memory Impairment

被引:32
作者
Gironi, M. [1 ]
Bianchi, A.
Russo, A.
Alberoni, M.
Ceresa, L.
Angelini, A. [3 ]
Cursano, C. [3 ]
Mariani, E. [3 ]
Nemni, R.
Kullmann, C. [3 ]
Farina, E.
Boneschi, F. Martinelli [2 ]
机构
[1] Santa Maria Nascente Clin Res Ctr, Don Carlo Gnocchi Fdn, IRCCS, IT-20148 Milan, Italy
[2] Univ Milan, Osped San Raffaele, Div Neurosci, Sci Inst,Inst Expt Neurol INSPE, I-20127 Milan, Italy
[3] Polydiagnost Ctr, CAM, Monza, Italy
关键词
Oxidative stress; Antioxidant; Mild cognitive impairment; Parkinson's disease; Alzheimer's disease; Vascular risk factors; MILD COGNITIVE IMPAIRMENT; VASCULAR RISK-FACTORS; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; LIPID-PEROXIDATION; HIPPOCAMPAL VOLUME; LEWY BODIES; DEMENTIA; STRESS; GLUTATHIONE;
D O I
10.1159/000319452
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Byproducts of oxidative metabolic reactions could play a role in the pathogenesis of several neurodegenerative diseases (ND) including Alzheimer's disease (AD). We designed a study aimed at investigating a large set of oxidative and antioxidant markers in a sample of patients affected by different forms of dementia or memory impairment. Methods: Serum levels of coenzyme Q 10, malondialdehyde (MDA), the total, oxidized and reduced forms of glutathione (GStot, GSSG and GSH, respectively), reactive oxygen species, anti-oxidized low-density lipoprotein antibodies and antioxidant power (PAO) were investigated in patients affected by AD, mild cognitive impairment, dementia with Lewy bodies and Parkinson's disease with dementia. The patient sample (n = 66) was compared with healthy subjects (HC; n = 62), and a comparison across pathological subgroups was also performed. A multivariate logistic regression model was implemented in order to calculate an algorithm model for predicting the risk of developing a neurodegenerative disorder. Results: The comparison between the memory deficit (MD) group and HC showed a significant difference for MDA (MD: 6.3 +/- 2.8 mu g/l; HC: 9.1 +/- 8 4.9 mu g/l; p = 1.7 x 10(-6)), GStot (MD: 260.4 +/- 62.6 mg/l; HC: 306.5 +/- 60.7 mg/l; p = 2.2 x 10(-5)), GSH (MD: 208.9 +/- 68.4 mg/l; HC: 295.3 +/- 101.3 mg/l; p = 2.2 x 10(-7)) and PAO (MD: 1,066.5 +/- 247.7 mu mol; HC: 954.9 +/- 200.4 mu mol; p = 0.8 x 10(-3)). By contrast, no differences in the levels of the studied markers were detected across the different forms of ND. An older age, higher levels of PAO, lower levels of GSH and MDA and the use of cardiovascular or antidepressant drugs were the most important factors associated with the carrier ship of neurodegenerative disorder. Conclusion: To our knowledge, this is the first study reporting similar oxidative imbalance in different forms of memory impairment, regardless of the specific etiology. Low GSH levels could be considered as a favorable factor in ND; at the same time it could be suggested that higher levels of PAO represent a counteracting mechanism against an increased oxidative stress. The association between vascular risk factors, depressive status and cognitive impairment is in line with findings in the literature. Copyright (c) 2010 S. Karger AG, Basel
引用
收藏
页码:129 / 137
页数:9
相关论文
共 48 条
[1]   Gender differences in the incidence of AD and vascular dementia - The EURODEM Studies [J].
Andersen, K ;
Launer, LJ ;
Dewey, ME ;
Letenneur, L ;
Ott, A ;
Copeland, JRM ;
Dartigues, JF ;
Kragh-Sorensen, P ;
Baldereschi, M ;
Brayne, C ;
Lobo, A ;
Martinez-Lage, JM ;
Stijnen, T ;
Hofman, A .
NEUROLOGY, 1999, 53 (09) :1992-1997
[2]   Regulation of Neuronal Glutathione Synthesis [J].
Aoyama, Koji ;
Watabe, Masahiko ;
Nakaki, Toshio .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 108 (03) :227-238
[3]   Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death [J].
Bains, JS ;
Shaw, CA .
BRAIN RESEARCH REVIEWS, 1997, 25 (03) :335-358
[4]  
Beal MF, 2003, ANN NY ACAD SCI, V991, P120
[5]   The prevalence of dementia in 95 year olds [J].
Börjesson-Hanson, A ;
Edin, E ;
Gislason, T ;
Skoog, I .
NEUROLOGY, 2004, 63 (12) :2436-2438
[6]   Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias [J].
Casado, Angela ;
Lopez-Fernandez, Ma Encarnacion ;
Casado, Ma Concepcion ;
de la Torre, Rosario .
NEUROCHEMICAL RESEARCH, 2008, 33 (03) :450-458
[7]   Oxidants and the pathogenesis of lung diseases [J].
Ciencewicki, Jonathan ;
Trivedi, Shweta ;
Kleeberger, Steven R. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (03) :456-468
[8]   Clinical diagnostic criteria for dementia associated with Parkinson's disease [J].
Emre, Murat ;
Aarsland, Dag ;
Brown, Richard ;
Bum, David J. ;
Duyckaerts, Charles ;
Mizuno, Yoshikino ;
Broe, Gerald Anthony ;
Cummings, Jeffrey ;
Dickson, Dennis W. ;
Gauthier, Serge ;
Goldman, Jennifer ;
Goetz, Christopher ;
Korczyn, Amos ;
Lees, Andrew ;
Levy, Richard ;
Litvan, Irene ;
McKeith, Ian ;
Olanow, Warren ;
Poewe, Werner ;
Quinn, Niall ;
Sampaio, Christina ;
Tolosa, Eduardo ;
Dubois, Bruno .
MOVEMENT DISORDERS, 2007, 22 (12) :1689-1707
[9]   CHEMISTRY AND BIOCHEMISTRY OF 4-HYDROXYNONENAL, MALONALDEHYDE AND RELATED ALDEHYDES [J].
ESTERBAUER, H ;
SCHAUR, RJ ;
ZOLLNER, H .
FREE RADICAL BIOLOGY AND MEDICINE, 1991, 11 (01) :81-128
[10]   Fundamental aspects of reactive oxygen species, or what's the matter with oxygen? [J].
Fridovich, I .
OXIDATIVE/ENERGY METABOLISM IN NEURODEGENERATIVE DISORDERS, 1999, 893 :13-18